Influence of host genetics on the severity of coccidioidomycosis
- PMID: 10511523
- PMCID: PMC2627717
- DOI: 10.3201/eid0505.990508
Influence of host genetics on the severity of coccidioidomycosis
Abstract
Coccidioidomycosis, a mild flulike illness in approximately 40% of infected persons, progresses to severe pulmonary or disseminated disease in 1% to 10% of symptomatic cases. We examined host genetic influences on disease severity among class II HLA loci and the ABO blood group. Participants included African-American, Caucasian, and Hispanic persons with mild or severe disseminated coccidioidomycosis from Kern County, California. Among Hispanics, predisposition to symptomatic disease and severe disseminated disease is associated with blood types A and B, respectively. The HLA class II DRB1*1301 allele marks a pre-disposition to severe disseminated disease in each of the three groups. Reduced risk for severe disease is associated with DRB1*0301-DQB1*0201 among Caucasians and Hispanics and with DRB1*1501-DQB1*0602 among African-Americans. These data support the hypothesis that host genes, in particular HLA class II and the ABO blood group, influence susceptibility to severe coccidioidomycosis.
Similar articles
-
Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls.Ann Rheum Dis. 2010 May;69(5):822-7. doi: 10.1136/ard.2009.111906. Epub 2009 Jul 12. Ann Rheum Dis. 2010. PMID: 19596691 Free PMC article.
-
Population and family studies of HLA-DR4 by use of oligonucleotide typing.Tissue Antigens. 1992 May;39(5):266-71. doi: 10.1111/j.1399-0039.1992.tb01946.x. Tissue Antigens. 1992. PMID: 1412412
-
HLA class I and II alleles in susceptibility to ankylosing spondylitis.Ann Rheum Dis. 2019 Jan;78(1):66-73. doi: 10.1136/annrheumdis-2018-213779. Epub 2018 Oct 19. Ann Rheum Dis. 2019. PMID: 30341055 Free PMC article.
-
Association of HLA and post-schistosomal hepatic disorder: a systematic review and meta-analysis.Parasitol Int. 2011 Dec;60(4):347-56. doi: 10.1016/j.parint.2011.05.008. Epub 2011 Jun 12. Parasitol Int. 2011. PMID: 21664486 Review.
-
Extrapulmonary Coccidioidomycosis Among Children in Central California: A Retrospective Review.Pediatr Infect Dis J. 2019 Dec;38(12):1189-1194. doi: 10.1097/INF.0000000000002470. Pediatr Infect Dis J. 2019. PMID: 31738333 Review.
Cited by
-
Coccidioidomycosis in Immunocompromised at a Non-Endemic Referral Center in Mexico.J Fungi (Basel). 2024 Jun 18;10(6):429. doi: 10.3390/jof10060429. J Fungi (Basel). 2024. PMID: 38921414 Free PMC article.
-
The Known and Unknown "Knowns" of Human Susceptibility to Coccidioidomycosis.J Fungi (Basel). 2024 Mar 28;10(4):256. doi: 10.3390/jof10040256. J Fungi (Basel). 2024. PMID: 38667927 Free PMC article. Review.
-
The Host Response to Coccidioidomycosis.J Fungi (Basel). 2024 Feb 25;10(3):173. doi: 10.3390/jof10030173. J Fungi (Basel). 2024. PMID: 38535182 Free PMC article. Review.
-
Outcomes with severe pulmonary coccidioidomycosis and respiratory failure in the United States.J Assoc Med Microbiol Infect Dis Can. 2023 Mar 1;8(1):40-48. doi: 10.3138/jammi-2022-0028. eCollection 2023 Mar. J Assoc Med Microbiol Infect Dis Can. 2023. PMID: 37008578 Free PMC article.
-
Advocating for Coccidioidomycosis to Be a Reportable Disease Nationwide in the United States and Encouraging Disease Surveillance across North and South America.J Fungi (Basel). 2023 Jan 5;9(1):83. doi: 10.3390/jof9010083. J Fungi (Basel). 2023. PMID: 36675904 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
